Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Charles River Laboratories Intl
(NY:
CRL
)
273.82
USD
+5.66 (+2.11%)
Official Closing Price
Updated: 7:00 PM EST, Mar 5, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
354,100
Open
269.59
Bid (Size)
244.42 (1)
Ask (Size)
292.00 (10)
Prev. Close
268.16
Today's Range
259.02 - 274.81
52wk Range
95.58 - 303.79
Shares Outstanding
47,911,809
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Charles River Laboratories Announces Strategic Partnership with Kibur Medical to Advance Preclinical Oncology Studies
February 25, 2021
Today, Charles River announced a partnership with Kibur Medical to offer exclusive access to its IMD for in vivo preclincal oncology studies.
From
Business Wire News Releases
Charles River Laboratories Announces Fourth-Quarter and Full-Year 2020 Results and Provides 2021 Guidance
February 17, 2021
Charles River Laboratories Announces Fourth-quarter and Full-year 2020 Results and Provides 2021 Guidance
From
Business Wire News Releases
Performance
YTD
+9.67%
+9.67%
1 Month
+1.43%
+1.43%
3 Month
+15.84%
+15.84%
6 Month
+34.92%
+34.92%
1 Year
+76.56%
+76.56%
More News
Read More
Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development
February 17, 2021
From
Business Wire News Releases
Notable ETF Inflow Detected - MDY, GNRC, SEDG, CRL
March 01, 2021
Tags
ETFs
From
ETF Channel
Charles River Announces Strategic Partnership with Cypre, Expanding 3D In Vitro Services for Cancer Immunotherapy and Targeted Therapy Drug Screening
January 28, 2021
From
Business Wire News Releases
A Look Into Charles River's Debt
February 18, 2021
Tags
News
Markets
CRL
From
Benzinga
Charles River Laboratories Schedules Fourth-Quarter 2020 Earnings and 2021 Guidance Release and Conference Call
January 20, 2021
From
Business Wire News Releases
Charles River Partners with JADE Biomedical to Expand Biologics Capabilities
January 14, 2021
From
Business Wire News Releases
Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
January 11, 2021
From
Business Wire News Releases
Charles River: Q4 Earnings Insights
February 17, 2021
Tags
CRL
Market News
Earnings
From
Benzinga
Charles River Laboratories Acquires Distributed Bio
January 04, 2021
From
Business Wire News Releases
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.